Podcasts about bayh

Rob Sahr is a shareholder in Wolf Greenfield's Biotechnology Practice. He develops strategies for life science companies to maximize exclusivity for therapeutic and diagnostic products. Rob has also assisted federal grant recipients and contractors with Bayh-Dole compliance.Originally passed at the end of 1980, the Bayh–Dole Act permits ownership by contractors of inventions arising from federal government-funded research. In recent months, the Biden Administration has seemed intent on more aggressively exercising “march-in rights” under the Act to promote affordability of taxpayer-funded inventions.In this edition of IP Talk with Wolf Greenfield, Rob provides insight on recent developments regarding Bayh-Dole compliance. Here are the highlights.00:59 - On the contentiousness of Bayh-Dole03:06 - What is a subject invention and why are they the source of so much confusion?04:59 - Defining “march-in rights” and how are they different from “taking title” 06:16 - The four requirements of march-in rights 07:04 - Explaining “timely disclosure” and its importance08:34 - Implications of the recent University of South Florida case10:28 - Enforcing the requirements around utilization reports and how the Presidential election might factor into the equation###

The National Institute of Standards and Technology (NIST) seeks comments on the Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights, which sets out the factors that an agency may consider when deciding whether to exercise Bayh-Dole march-in rights. The information received will inform NIST and the Interagency Working Group for Bayh-Dole (IAWGBD) […]

The National Institute of Standards and Technology (NIST) seeks comments on the Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights, which sets out the factors that an agency may consider when deciding whether to exercise Bayh-Dole march-in rights. The information received will inform NIST and the Interagency Working Group for Bayh-Dole (IAWGBD) in developing a final framework document that may be used by a funding agency when making a march-in decision.This panel seeks to answer what the new framework is while also debating the pros and cons. This FedSoc Forum aims for participants to have a better understanding of this proposed policy change, be able to assess the impact should it be enacted, and be motivated to actively engage in the ongoing debate.

Adam Mossoff is a George Mason University/Antonin Scalia Law School Professor. Interpretations of the Bayh-Dole Act and Rx price fixing efforts by the Biden administration

The son of the late U.S. Senator Birch Bayh, the former governor of Indiana went on to take his father's Senate seat.

For the last several years in DC, a debate has raged as to the appropriate roles of industry, academia, and the NIH for R&D in the biopharma sector. With the Biden Administration committed to organizing a multi-agency review of the Bayh-Dole Act, many top-tier U.S. research universities are sounding alarm bells over the potential risks this could pose to the American innovation ecosystem. In this Vital Health Podcast, Duane Schulthess speaks with Kate Hudson, the Associate Vice President and Counsel for Policy at the Association of American Universities (AAU), regarding the risks of fundamental changes to the Bayh-Dole Act. Kate's role at the AAU includes intellectual property, technology transfer, public access, data privacy, and copyright issues. She has also served as a senior advisor in the legislative and executive branches, most recently with the U.S. Government Accountability Office (GAO).See omnystudio.com/listener for privacy information.

On this Vital Health Podcast, we speak to Joseph Allen, the Executive Director of the Bayh-Dole Coalition. Joe served as a Senior Staff Member of former Senator Birch Bayh and was instrumental in working behind the scenes to ensure the passage of the historic Bayh-Dole Act. The Wall Street Journal has stated that The Bayh-Dole Act is one of the three greatest policies that helped create U.S. Jobs. Passed in 1980 with the bipartisan sponsorship of Senators Birch Bayh and Bob Dole, the act allowed for university researchers that had received government funding to license important discoveries commercially. However, recent comments by members of the U.S. Senate and Biden Administration are threatening to upend the Bayh-Dole act, with increasingly bellicose demands for the government to ‘march-in' and take back patents licensed under Bayh-Dole. Joe Allen provides many historical insights into the passage of the Bayh-Dole act, and outlines how this would be a disaster for U.S. patients and biopharma innovation. See omnystudio.com/listener for privacy information.

Episode 6. Season 2 of Common Ruin begins with Marxist activist and Platonist philosopher Chanel Bayhí reading Bertrand Russell's 1927 essay "Why I Am Not a Christian" with Michael Acuña, and both debating the existence of God.  *DISCLAIMER: The views of host do not necessarily reflect those of the guest.  Music by Karl Casey @WhiteBatAudio --- Support this podcast: https://podcasters.spotify.com/pod/show/common-ruin/support

Today on Scope Conditions: why the judge's gavel is sometimes mightier than the sword.Political trials – or show trials – are a well-known mode of repression in authoritarian settings. We often think of a show trial as a sham version of the real thing: the autocrat affords his enemy a semblance of due process to give off the appearance of fairness, even though in reality, the fix is in. On this view, the show trial helps to legitimize arbitrary rule.Our guest today, Dr. Fiona Shen-Bayh, an assistant professor of Government at the College of William and Mary, tells us that this common understanding of political trials gets things only half right. Sure, the outcome of a show trial is pretty much pre-ordained. But political trials aren't concessions to norms of legal fairness. Rather, Fiona argues, the trial – the ritual, storytelling, and publicness of a judicial process – is itself a key tool of repression and power-maintenance, especially for rulers facing threats that they can't see.We have a terrific conversation with Fiona about her new book, Undue Process: Persecution and Punishment in Autocratic Courts, an analysis of the political logic of show trials in post-independence Anglophone Africa. Fiona explains to us how the pomp and ceremony of the courtroom helps undermine coordination among the dictator's enemies. We also talk about how autocrats choose between assassinating their opponents and putting them on trial, and about how African dictators find judges who are both competent enough to run a good trial and compliant enough to rig the outcome. Fiona also tells us how she painstakingly dug through archives to construct an original dataset of coup plots and repressive responses.  We learn how Fiona dealt with the challenge of identifying unsuccessful coup plots and what happened to the plotters – over many decades in seven African countries. Records inside these countries were sparse, so she immersed herself instead in the shadow archives. And if you don't know what a shadow archive is, you'll want to listen to find out. We also talk with Fiona about how she managed the inevitable uncertainties of deep archival work – of not knowing whether your months of digging through the files will turn up anything useful.This is a conversation about courts as political institutions. And we close it out by asking Fiona to reflect on whether this is just an autocratic dynamic, or one that afflicts democracies too. At the end of the day, what is it that keeps courts in liberal democracies from merely serving political ends?

Innovation in life sciences is crucial for many key industries in the United States and across the globe. It supports advances in human biotechnology, pharmaceuticals, health care policy, and beyond. Such advances would not always have been possible without the Bayh-Dole Act. Rob and Jackie sat down with Joe Allen, who served as a professional staffer on the U.S. Senate Judiciary Committee to former Senator Birch Bayh, to discuss the importance of the Bayh-Dole Act and the future of life sciences innovation. RelatedStephen Ezell, “The Bayh-Dole Act's Vital Importance to the U.S. Life-Sciences Innovation System” (ITIF, March 2019). “Preserving Bayh-Dole—the “Inspired” Law That Underpins U.S. Leadership in Life-Sciences Innovation” (ITIF Event, March 2019).Stephen Ezell, “How Japan Squandered Its Biopharmaceutical Competitiveness: A Cautionary Tale” (ITIF, July 2022).

With the Center for Medicare and Medicaid Services' recent decision to limit access to Biogen's Alzheimer's treatment, and with drug pricing sure to be one of the central issues of the looming mid-term elections, Arizona Senator Kyrsten Sinema's support of the biopharma sector places her state at ground zero of the drug pricing debate. Stepping directly into the fray, Danny Seiden, CEO of the Arizona Chamber of Commerce, recently published an article for Real Clear Policy titled Bye-bye Bayh. In it, Danny argues that the recent threats by members of the US Senate to exercise little-known and rarely used legal provisions called march-in rights contained in the Bayh-Dole legislation would, “crush American innovation, creating a new avenue for government to punish companies for bringing products – including lifesaving treatments – successfully to market.”   Phoenix is one of the fastest growing biopharma regions in America, and this is in no small part due to Danny Seiden and the Arizona Chamber of Commerce working with their state and federal representatives to ensure that their economy balances the needs of business and the public. Danny makes a compelling case that the current discussions on drug pricing are rarely based on evidence, and to address rising healthcare costs there is a critical need for market driven solutions which also promote scientific innovation. See omnystudio.com/listener for privacy information.

Bayh-Dole helped the U.S. reverse its downward spiral into irrelevance and become the dominant force that it is today. The world economy is unraveling again, and Joe Allen is a firm believer in the power of the Bayh-Dole Act to turn things around for countries across the world. Not everybody agrees. Despite the fact that the Bayh-Dole Act is foundational to the U.S. economy, it has been under attack since it was passed in 1980. From day one, Joe Allen has been there to fight the battles on its behalf. Listen to this episode to hear why protecting Bayh-Dole means protecting innovation.    In This Episode: [00:52] An overview of Joe Allen's career, from Senate Judiciary Committee for Senator Birch Bayh to leader of the Bayh-Dole Coalition. [02:12] March-in right requests that have been filed relating to the prostate cancer drug, XTANDI. [03:15] Why the US patent system is under attack. [04:10] The profound impact that the Bayh-Dole Act had on the US economy.  [06:09] Joe explains why the Bayh-Dole Act has the provision of a march-in right.   [07:30] Four circumstances under which the government can invoke the march-in provision.  [09:04] Misconceptions held by opponents of the Bayh-Dole Act.   [16:16] The enormity of what is at stake if the march-in relating to XTANDI goes ahead. [21:20] Attacks that were waged against Bayh-Dole when it was passed. [23:26] An explanation of the Exceptional Circumstances provision in the Bayh-Dole Act, and how the DOE is trying to take advantage of this.  [30:23] The dangers of micromanagement in the innovation space.  [33:54] How the COVID-19 mRNA vaccine came into existence in such a short space of time.   [39:27] Joe shares his thoughts on COVID-19 vaccine patent waivers.   [43:53] The role that Joe played in assisting South Africa to change its approach to innovation.  [48:04] Joe's passion for advocating for the Bayh-Dole Act in the US and internationally.  [49:30] A story that epitomizes the driving force behind our economy.  [50:30] Why Joe is optimistic about the future of Bayh-Dole, despite the many reasons not to be.  [53:02] The most effective way to fight back against Bayh-Dole oppressors.  [55:42] A story that highlights the real-world value of the Bayh-Dole Act.    Find Joe: Email  

Evan Bayh was destined for a life in politics and he wasted little time in making his mark, taking office as Indiana's 46th Governor at the age of 33. In this episode, the son of legendary Senator Birch Bayh talks about a visit to New Hampshire that sparked his political passion, a covert vice presidential discussion over hamburgers with Barack Obama and life beyond politics.

Evan Bayh is one of only two Hoosiers to win statewide elective office at least five times. He was a governor, a United States Senator, and now we're happy to say he's our guest on the “Leaders and Legends” podcast. We talk with him about his career, what it was like to grow up with such formidable parents, and how proud he is of the people who have worked for him. Our friend Jim Shella joins us for the conversation.Sponsors• Veteran Strategies• Girl Scouts of Central Indiana• MacAllister Machinery• Garmong Construction• Crowne Plaza Downtown Indianapolis Historic Union StationAbout Veteran Strategies‘Leaders and Legends' is brought to you by Veteran Strategies—your local veteran business enterprise specializing in media relations, crisis communications, public outreach, and digital photography. Learn more at www.veteranstrategies.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Today on the Naturally Inspired Daily Clip Tammy Talks About:  Schools being closed all over America, Mikki Willis on Naturally Inspired Podcast and Sharyl Attkisson explains AstroTurfing.  

In some ways, the Bayh-Dole Act saved the United States, and our guest on today's show played a key role in its adoption. Joe Allen was part of the US Senate Judiciary Committee for Birch Bayh, the senator whose name makes up one part of the Act which was deemed one of the most inspired pieces of legislation that America had seen in half a century.  The intention of the Act was to foster R&D partnerships between universities and US industry in order to put an end to the government's practice of spending billions of dollars on research and then never commercializing it. In today's episode, Joe shares why the Act was so transformative, as well as the tumultuous journey he and his team went on to get it passed, which, looking back, seems like a miracle.   Joe's impressive career doesn't end there, and you will also hear about what he achieved in his roles as Executive Director of Intellectual Property Owners Inc., the Director of the Office of Technology Commercialization, the Vice President of the NTCC, the co-founder of the Entrepreneurial Technology Apprentice Program, and now as the owner of Joseph Allen and Associates and Executive Director of the Bayh-Dole Coalition.   In This Episode: [00:51] A rundown of the colorful professional life of today's guest, Joe Allen. [03:36] The fortuitous event which led Joe to be part of the US Senate Judiciary Committee for Birch Bayh.    [05:51] Where the idea of the Bayh-Dole Act originated, and Joe's role in the process.  [07:00] The amount of R&D that was government funded at the time the Bayh-Dole Act came into place, and how that has changed since the passing of the Act.  [08:08] Why Senator Bayh and Senator Dole were an unusual combination, and why this didn't matter. [09:36] The crisis that the Bayh-Dole Act saved the United States from. [11:21] Challenges that Joe and his team experienced in getting the bill passed.  [13:23] What the invention landscape looked like pre the Bayh-Dole Act. [16:06] The rocky road to adoption of Bayh-Dole Act.    [18:05] Joe shares what happened in the final moments of getting the Bayh-Dole Act passed.  [23:00] Two questions that Joe was asked just before the bill was cleared.   [24:16] How Joe became involved with the IPO, and the work that he did there. [26:34] Why bureaucrats attacked the Bayh-Dole Act, and the office Joe ran that served to uphold it. [28:17] Benefits of the Federal Technology Transfer Act, which Joe was instrumental in the creation of. [31:56] Joe's introduction to the National Technology Transfer Centre (NTCC), and why he decided to take the opportunity to work there.    [32:53] Goals of the NTTC, awards they won, and the training program that they ran.  [35:03] Intentions of the Bayh-Dole Coalition that Joe co-founded. [37:18] An explanation of an executive order recently issued by Joe Biden. [38:49] Concerns that Congress had about the Bayh-Dole Act, and the provision which was put in place as a result.  [40:22] The paper that came out 20 years after the Bayh-Dole Act was passed, and the concern that it caused. [42:49] A regulation that Congress proposed around march in rights relating to the Bayh-Dole Act. [43:26] How Biden's executive order potentially threatens the Bayh-Dole Act. [44:40] The number of start-up companies that are continuously being founded because of the Bayh-Dole Act.  [45:24] Why Joe is worried about the future of the Bayh-Dole Act.   [46:36] The experience that made Joe aware of the lack of diversity in the technology transfer field.     [48:22] Joe's involvement in the Entrepreneurial Technology Apprentice Program (ETAP), which aimed to expose children from underrepresented groups to technology transfer. [50:09] Success of the ETAP pilot program.   [51:31] The achievement that Joe is most proud of.      Find Joe: Email The Bayh-Dole Coalition

In 1980, the Bayh-Dole Act was enacted by U.S. Congress, which changed how ownership of an invention is pursued. Almost 40 years later, how has this act fared?On Episode 1 of Making Medicine, John Stanford, Executive Director of Incubate Coalition, introduces Joseph Allen and Associates to cover:- How Bayh-Dole came to be, starting with Purdue University - The original intent of ‘march-in' rights and how it affects Bayh-Dole- Who was this act for, and how has it played out 40 years later?As we begin on this new journey together, we would love to hear from you, the listener. Email John@incubatecoalition.org or Ashlyn@incubatecoalition.org what's top of mind, what story you want to hear, or what you find interesting!To hear more interviews like this one, subscribe to Making Medicine on Apple Podcasts, Spotify, or your preferred podcast platform.

Karen Kerrigan, SBE Council (SBECouncil.org), on NIST proposed comments reaffirming intent of 1980 Bayh-Dole Act; the latest on big infrastructure package & impact of corporate tax increase; antitrust & small business; updates on PPP & SVOG program.

Today: We revisit our conversation with Chris Bayh, the son of former Senator Birch Bayh, and Joe Allen, a former Bayh staffer who now heads up the "Bayh-Dole-40" initiative that marks the 40th anniversary (actually observed earlier this month) of the passage of the Bayh-Dole Act. The Bayh-Dole Act fundamentally changed the nation's system of technology transfer, by enabling universities to retain title to inventions and take the lead in patenting and licensing groundbreaking discoveries. We also have Tami Silverman with the Indiana Youth Institute to talk about her latest column entitled " Still Home for the Holiday: Supporting Our Kids Over Break." Young people usually await the holidays to enjoy being with friends and family, as well as the presents. But the pandemic changed all that and added stress to the holiday plans. Tami offers some tips in dealing with that stress.

The spotlight has shined brightly on Indiana State Department of Health Commissioner Dr. Kristina Box. She would prefer being behind the scenes working with her team and digging into the numbers but accepts the upfront role as part of dealing with COVID-19. The “overwhelming negative response to being asked to wear masks” has been surprising, she says, and the uncertainty – “the only guarantee with this pandemic is it’s going to change” – has been challenging. She talks about the team effort, the early influence that led her to a medical career and areas of progress in other important areas of health care. Learn more:Indiana State Department of Health (www.in.gov/isdh)BizVoice magazine feature story (www.bizvoicemagazine.com/interactive/2020/11/#p=30)

The spotlight has shined brightly on Indiana State Department of Health Commissioner Dr. Kristina Box. She would prefer being behind the scenes working with her team and digging into the numbers but accepts the upfront role as part of dealing with COVID-19. The “overwhelming negative response to being asked to wear masks” has been surprising, she says, and the uncertainty – “the only guarantee with this pandemic is it's going to change” – has been challenging. She talks about the team effort, the early influence that led her to a medical career and areas of progress in other important areas of health care. Learn more:Indiana State Department of Health (www.in.gov/isdh)BizVoice magazine feature story (www.bizvoicemagazine.com/interactive/2020/11/#p=30)See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Historically, circumstances under which a federal agency has requested transfer of patent title under the amended Bayh-Dole Act have been rare. However, times and circumstances have changed. On this episode, patent partner, Jeff Morton, discusses the possibility of a federal agency requesting transfer of title for a patent that covers COVID-19 antibody treatment.

Today: Republicans and Democrats can't seem to agree on anything these days -- but it wasn't always that way. Forty years ago, then-U.S. Senators Birch Bayh of Indiana and Bob Dole of Kansas agreed that the country's public research and development system was inefficient and they worked "across the aisle" to fix it. On today's program, Birch Bayh's son Chris and Joe Allen, one of Bayh's former staffers, talk about the 40th anniversary of the Bayh-Dole Act and its major importance to the U.S. economy. We bring you the first of a series of Darian Benson's conversations on young women who are pushing for change in their Indiana communities. And Indiana Public Broadcasting's Justin Hicks spoke with an activist who has turned one block of Main Street in Goshen into a lightning rod for political tension, and perhaps, even conversation.

Activists and politicians have responded to the worldwide COVID-19 pandemic by calling for the elimination of patent rights on treatments or cures. Some have even called for outright confiscation by the government of any patents on tests, treatments, and vaccines. This teleforum will discuss how the biopharmaceutical industry has responded to the COVID-19 pandemic and consider the role played by reliable and effective patent rights in biotech innovations in making this response possible.Are patents and patent licensing, including the licensing of university-patented inventions through the Bayh-Dole regime, essential legal and economic drivers of successful innovation in 21st-century healthcare? How might patents, patent licensing, and the tech transfer process created by the Bayh-Dole Act provide key legal and policy tools for companies to respond effectively to our current health crisis and crises to come? These and other questions will be discussed in this teleforum.Featuring:- Lesley Millar-Nicholson, Director, Technology Licensing Office & Director, Catalysts, Office of Strategic Alliances & Technology Transfer, MIT- Brian P. O'Shaughnessy, Partner, Dinsmore & Shohl LLP and Past President, Licensing Executives Society, USA & Canada- Corey Salsberg, Vice President, Global Head IP Affairs, Novartis- [Moderator] Adam Mossoff, Professor of Law, Antonin Scalia Law School, George Mason UniversityVisit our website – www.RegProject.org – to learn more, view all of our content, and connect with us on social media.

James and Melissa take a listener call about former Indiana Governor Evan Bayh. Melissa reviews Hulu/BBC's Normal People and the Blago episode of Trial by Media. James reviews the Jenny Jones episode of Trial by Media. They also celebrate the 20th anniversary of Britney's Oops I Did It Again album.

Were you aware that there are two research organizations at Georgia Tech? Listen to Lisa and her guest, Dr. Terry Bray, the Director of Technology Licensing at Georgia Tech Research Corporation, as they discuss this and many other intellectual property topics on this episode of Tech Transfer IP. Terry has over twenty-five years of experience in the creation, development, and commercialization of innovative technologies. Before joining GTRC, Terry held positions such as the Executive Vice President of Business Development at Atherotech Diagnostics Lab at the University of Alabama at Birmingham, to name a few. He has extensive experience in the management, patenting, and licensing of intellectual property and facilitating start-up company formation and economic development. Terry shares how his office is organized and the work they do, he speaks about the impact the Bayh-Dole Act has had on universities and about the substantial money they were awarded for new research. Terry also discusses how Georgia Tech has made it easier to work with Industry partners, changes his office has made that allows them to work more efficiently with corporate partners. He also chats about PCT’s and foreign filings. Listen as Terry speaks about philanthropic foundations that they partner with, some of his office’s most significant success stories, and the top three challenges his office faces today. Terry says that his office is very blessed, but if he had three wishes, he would ask for more talented team members to enable productivity. If you have questions for Terry on what he spoke about today or know someone who might want to connect with Georgia Tech and see if there is any researcher they might want to contact to partner with GTRC, please contact him via terry.bray@industry.gatech.edu.   In This Episode: [02:33] Terry, welcome to the show! [03:19] Terry speaks about the two organizations at Georgia Tech, the GTRC, and GTARC. [04:51] How is your office organized, and how do you work? [07:03] Terry discusses the impact that the Bayh-dole Act has had on innovation at universities. [08:34] Is there anything you would change about Bayh-Dole? [09:28] Terry shares why Georgia Tech received substantial money they were awarded for new research. [11:21] Terry chats about how Georgia Tech has made it easy for corporate partners to work with them through their Industry Engagement group. [14:17] Terry speaks about the metrics for the office and what they are gaged by. [15:58] How do you research your disclosures? Is there anything unique you look for in disclosures? [17:21] Terry discusses PCT’s and foreign filings. [19:33] Terry shares what his office does with litigation and how aggressively they proceed. [21:45] Can you talk about the changes your office made around interacting with corporate partners? [24:42] Terry chats about their relationship with philanthropic foundations like Gates, for example. [26:01] Can you tell us about some of your offices’ most significant success stories? [27:45] Terry shares his office's three top challenges right now. [30:38] Terry speaks about AUTM and other organizations that provide membership and services. [32:30] Does credentialing make a difference in your office, is it something you look for when hiring? [33:46] Terry describes what he would wish for his office if he had three wishes. [37:19] Thank you so much for being here today!   Find Terry: Terry Bray Georgia Tech Research Corporations @terrybray LinkedIn

ABOUT THIS EPISODE Concerns about Donald Trump's fitness to serve as U.S. President have motivated many people to advocate for the invocation of the 25th Amendment, particularly Section 4. Those who have engaged in such advocacy--and I've done it--seem to believe that effectively invoking Section 4 of the 25th Amendment could be a way to remove Trump from office. But my guest--Brian Kalt of the Michigan State University College of Law--makes a case that we're wrong. LINKS --Brian Kalt's MSU profile (https://www.law.msu.edu/faculty_staff/profile.php?prof=44) --Unable: The Law, Politics, and Limits of Section 4 of the Twenty-Fifth Amendment (by Brian Kalt) (https://www.amazon.com/Unable-Politics-Section-Twenty-Fifth-Amendment/dp/0190083190) --"President Trump is unfit for this crisis. Period." (by Jennifer Senior, at The New York Times) (https://www.nytimes.com/2020/03/09/opinion/trump-corona-cdc.html) --"Bayh aide not surprised 25th Amendment hasn't removed a president" (by Maureen Groppe, at The Indianapolis Star) (https://www.indystar.com/story/news/politics/2017/09/14/bayh-aide-not-surprised-25th-amendment-hasnt-removed-president/639442001/) --_Full Disclosure: A Novel _(by William Safire) (https://www.amazon.com/Full-disclosure-novel-William-Safire/dp/0385121156) Special Guest: Brian Kalt.

Today on All IN we explore the life and legacy of the late U.S. Senator Birch Bayh, and what we can learn from an era of American government noted for compromise and bipartisanship.

birch-bayh https://files.fireside.fm/file/fireside-uploads/images/4/43f8ab4b-615b-4fa3-83f7-01fc9ec2f2bc/1hAX3tuR.jpg Birch Bayh was a titan of modern Indiana politics and an exemplar of public service. Sadly, as we did Senator Richard Lugar, we lost Senator Bayh earlier this year. On today’s “Leaders and Legends” podcast we talk with former Bayh staffers Louis Mahern, Bob Blaemire, and Nancy Papas about the life, times, and career of an unforgettable Hoosier statesman. Sponsors: * Veteran Strategies (https://veteranstrategies.com/) * Girl Scouts of Central Indiana (https://www.girlscoutsindiana.org/) About Veteran Strategies ‘Leaders and Legends’ is brought to you by Veteran Strategies—your local veteran business enterprise specializing in media relations, crisis communications, public outreach, and digital photography. Learn more at www.veteranstrategies.com (www.veteranstrategies.com). About Girl Scouts of Central Indiana We're 2.5 million strong—more than 1.7 million girls and 750,000 adults who believe in the power of every G.I.R.L. (Go-getter, Innovator, Risk-taker, Leader)™ to change the world. Our extraordinary journey began more than 100 years ago with the original G.I.R.L., Juliette Gordon “Daisy” Low. On March 12, 1912, in Savannah, Georgia, she organized the very first Girl Scout troop, and every year since, we’ve honored her vision and legacy, building girls of courage, confidence, and character who make the world a better place. We’re the preeminent leadership development organization for girls. And with programs from coast to coast and across the globe, Girl Scouts offers every girl a chance to practice a lifetime of leadership, adventure, and success. To volunteer, reconnect, donate, or join, visit girlscoutsindiana.org (https://www.girlscoutsindiana.org/) or call 317.924.6800.

Experienced opinion-gatherer Jeff Lewis talks about two Indiana statesmen, Senators Bayh and Lugar, both having recently passed away. Among topics are challenges facing polling organizations, how salience affects responses, whether the census (and, by extension, polling organizations) will find utility by using the internet, and dysfunction in present-day Washington, D.C. 

A hallmark of Mitch Daniels’ time as Indiana governor was the expansion of testing of Hoosier students. The tests given to K-12 students have never been more high-stakes than they are now, and that’s rankled plenty of teachers and administrators. Somewhat less rancor has been generated by the Purdue President’s latest testing proposal – a civics exam students would have to pass before they’re awarded a diploma. On this edition of WBAA’s Monthly Conversation With Mitch Daniels, we address how that test might be administered and whether another exam will solve the problem of American governmental illiteracy. Also on this month’s show, a remembrance of Purdue alum and Indiana Senator Birch Bayh. Mitch Daniels says he once worked on a Senate campaign trying to defeat Bayh, but later came to know him as so many did – a giant of public life whose days seem more bygone all the time.

Perry Metz interviews former Senator Birch Bayh in his Washington, D.C. office, where he discusses his political career, the influence of his late wife Marvella, and the allies he sought on both sides of the aisle.

Birch Bayh passes away at 91. Congress rejects Trump's emergency. That plus Pete Buttigieg's town hall and more on Indiana Week in Review for the week ending March 15th, 2019.

Birch Bayh passes away at 91. Congress rejects Trump's emergency. That plus Pete Buttigieg's town hall and more on Indiana Week in Review for the week ending March 15th, 2019.

Today on No Limits we honor and remember the life of Indiana Senator Birch Bayh who passed away today at the age of 91.

On today’s call, we welcomed a special guest – former two-term U.S. Senator and Governor of Indiana Evan Bayh, who recently joined Cozen O’Connor and Cozen O’Connor Public Strategies. Joining Howard Schweitzer, Mark Alderman, and Blake Rutherford, Senator Bayh shared insights from his time serving on the Senate Intelligence Committee and underscored his support for the confirmation of Gina Haspel as the next Director of the CIA. The conversation touched on the Trump administration’s impact on international affairs, as well as the economy. The Beltway Briefing is an ongoing series covering the news of the day and constantly-evolving state of play in Washington, D.C. hosted by Cozen O’Connor Public Strategies. Please email PublicStrategies@cozen.com to subscribe for updates on our upcoming calls, or visit our website at www.copublicstrategies.com.

Featuring: Lisa Ouellete (https://law.stanford.edu/directory/lisa-larrimore-ouellette/) from Stanford Law School Summary: In 1980, Congress enacted the Bayh-Dole Act, which is often considered the "basis of the biotech revolution." In this episode, we explore the impact of patents on federally funded research at universities and other institutions in the wake of Bayh-Dole with Lisa Ouellete, who has written extensively on the topic.

If you work in biotech, or venture capital, if you pay taxes, or take medicine… you really ought to know the name Joe Allen. He worked tirelessly behind the scenes in Washington to get the Bayh-Dole Act passed into law. Sponsored by Senators Birch Bayh and Bob Dole, and passed at the last possible opportunity in a lame duck session of Congress in 1980, it is the legislation that realigned the incentives of the patent system to enable small biotech companies and their investors to flourish. And Joe's been implementing, overseeing, protecting, sharing, and blogging about it ever since. 

The last gubernatorial debate. Will it matter? Bayh bashing. Help for Todd Young. The 9th District. Pence on the run. The problem with voter fraud allegations. Plus how not to earn publicity in a political campaign and more.

The last gubernatorial debate. Will it matter? Bayh bashing. Help for Todd Young. The 9th District. Pence on the run. The problem with voter fraud allegations. Plus how not to earn publicity in a political campaign and more.

It's your lucky day! We're doing a special Monday episode since we may not be able to find time later in the week. So check out our Senate-sational special!  Aldo, don't orget  to follow @margieomero & the #walmartmoms hashtag for groups Tuesday night.   Poll of the week Is Trump just making excuses, or might the election be rigged? A new ABC poll finds yet another big party divide. ABC News poll on Clinton's double-digit lead   The senate! The Upshot compares all the the handicappers and forecasters into one giant clip-n-save, or click-n-spin. NBC/WSJ poll on congressional preferences The upshot on Senate election forecast The New York Times on Senate election poll   Pennsylvania The New York Times on Pennsylvania Senate race Politico on Pennsylvania Senate race The New York Times endorsement of Katie McGinty   Indiana The New York Times on Indiana Senate race Politico on Evan Bayh's Collapse Associated Press on Bayh and job hunt Politico on Bayh's Indiana address   New  Hampshire The New York Times on New Hampshire Senate race Politico on New Hampshire Senate race   North carolina The New York Times on North Carolina Senate race Politico on North Carolina Senate race   Missouri The New York Times on Missouri Senate race Politico on Missouri Senate race   Nevada The New York Times on Nevada Senate race Politico on Nevada Senate race   Florida The New York Times on Florida Senate race   We've got issues Gallup poll on candidates and key issues Pew Research Center on spouse's preferences     Key Findings It's never too early to prepare for your next campaign, folks. The trump effect downticket may not be as big as people think. But it's definitely not helping. And if you're not feeling like you hear enough about the issues, call your spouse. Learn more about your ad choices. Visit megaphone.fm/adchoices

This week on IWIR - Tornados. Pence responds. A barber. Trump in Indiana. Bayh's address. Holcomb hands out checks plus troopers lip sync.

This week on IWIR - Tornados. Pence responds. A barber. Trump in Indiana. Bayh's address. Holcomb hands out checks plus troopers lip sync.

This week on IWIR - Trump selects Pence. Who replaces him on ballot? Bayh replaces Hill for Senate and Young's reaction. Winners & Losers.

This week on IWIR - Trump selects Pence. Who replaces him on ballot? Bayh replaces Hill for Senate and Young's reaction. Winners & Losers.

Former Indiana Senator Evan Bayh is among a group of moderate Democrats and Republicans who hope to make bipartisanship a winning issue at the polls.

The Empire Club of Canada Presents: Senator Evan Bayh, Former Governor of Indiana and U.S. Senator With Ontario's Nuclear Advantage Senator Bayh will discuss the important role Nuclear Power plays in the Great Lakes Region as a key source of reliable, affordable electricity, while growing the economy and keeping the air we breathe clean. Biography: Senator Evan Bayh is a former two term governor of Indiana and U.S. senator and currently serves as a strategic advisor for McGuireWoods and the Leadership of Nuclear Matters, which is a group dedicated to inform the public about the clear benefits that nuclear energy provides. Sen. Bayh had a very distinguished career in public service being elected overwhelmingly as Governor and Senator in his home state of Indiana. As a moderate Democrat, he was a leader, working in a bipartisan manner to seek consensus on several key issues, including financial services reform and healthcare. He was also a leading voice advocating fiscal restraint on government spending. Sen. Bayh served on several committees, including Armed Services; Banking, Housing and Urban Affairs, Energy and Natural Resources: Small Business and Entrepreneurship: Aging, and Senate Intelligence. Prior to being elected to the Senate, he was elected to two terms as governor of Indiana, where he enacted welfare reform, cut taxes, and brought about fiscal discipline to the state's budget. He also served as Secretary of State in Indiana, 1986 to 1989. Sen. Bayh also currently serves as a senior advisor at Apollo Global Management in New York and on the board of directors for Fifth Third Bank, Marathon Petroleum Corporation, Berry Plastics Corporation, RLJ Lodging Trust, and McGraw Hill Education. He also serves on the advisory board for the Central Intelligence Agency, CIA. Speaker: Senator Evan Bayh, Former Governor of Indiana and U.S. Senator *The content presented is free of charge but please note that the Empire Club of Canada retains copyright. Neither the speeches themselves nor any part of their content may be used for any purpose other than personal interest or research without the explicit permission of the Empire Club of Canada.* *Views and Opinions Expressed Disclaimer: The views and opinions expressed by the speakers or panelists are those of the speakers or panelists and do not necessarily reflect or represent the official views and opinions, policy or position held by The Empire Club of Canada.*

Evan Bayh won't run in 2016. Mike Pence talks foreign policy. Dan Coats supports the President, high tech state government, Paul George ignites a controversy plus another Pacer's tweet goes viral and more.

Former Indiana Governor and US Senator Evan Bayh joins the show from Washington, DC to talk with host John Krull.

Perry Metz interviews former Senator Birch Bayh in his Washington, D.C. office, where he continues to monitor court cases about equal opportunity.

We are pleased to welcome Samuel J. Petuchowski, Ph.D., from Sunstein Kann Murphy & Timbers LLP to this week's IP podcast. Dr. Petuchowski discusses university and inventor patent rights and Stanford v Roche in this podcast.

Preparing for a week of futile bipartisanship. Plus, Sarah Buttenwieser counsels Sen. Evan Bayh on his post-Senate career.

Great conversations and inspiring guests that parallel trending hot topics in life and culture

Adriana Barbaro discusses her new documentary on child marketing, "Consuming Kids." Plus, the urgent need to block the Blue Dogs from undermining President Obama's budget.

In the period following World War 2, government policy stipulated that whenever anything was invented using government funding, it would be put into the public domain. This may sound like an honorable idea, but the problem was that nothing was being commercialized because there was no incentive to do so.Since 1980, thanks to the Bayh-Dole Act, the commercialization of inventions has been in the hands of the inventors, and this has led the United States to become one of the most innovative nations in the world. However, for over 20 years, people have been fighting (unsuccessfully) against the Act, trying to distort its original goal. We're in the midst of one of those conflicts right now, so tune in today to hear from Joe Allen, the Executive Director of the Bayh-Dole Coalition who was instrumental in the passage of the Bayh-Dole Act, about the importance of keeping this Act intact and the grave consequences we face if we do not. In This Episode:[00:58] Introducing today's guest, Joe Allen, the Executive Director of the Bayh-Dole Coalition.[02:01] The purpose of the Bayh-Dole Act and how some lawmakers are trying to distort it. [03:37] The problem with the way government-funded inventions were treated in the period following WWII. [04:48] How Senator Bayh and Senator Dole transformed the innovation environment in the United States in 1980. [06:24] The intention behind the March-In Rights provision in the Bayh-Dole Act. [09:25] What opponents of the Bayh-Dole Act misunderstand about it. [12:21] A real-world example of the Bayh-Dole Act in action. [15:58] What the Bayh-Dole Act does and does not guarantee.[17:23] The issues we will face if the March-In provision is used for price control. [19:48] Why there is no case law that allows for March-In under Bayh-Dole. [20:09] Complexities of the March-In process.[22:10] Joe explains the link between the attempted misuse of the Bayh-Dole March-In Rights to the proposed abuse of Section 1498. [27:42] How to protect the Bayh-Dole Act. Resources:Joe Allen on LinkedInBayh-Dole Coalition